Reports Library Publication
Upper GIs: Investigating the Self-Care Market for Upper Gastrointestinals
21st December 2017 by Nicholas Hall Reports
Upper GIs
This report is an in-depth exploration of the Upper Gastrointestinals market, including antacids, antiflatulents, antinauseants, digestive enzymes and liver & bile remedies and includes coverage of 15 major markets from across the globe, with topline sales, brand performances, regulatory developments, launches and ad campaigns.
With mid-year sales from DB6 2017, data includes topline historical sales for region, country and category, plus individual brand performances and forecasts to 2021 and 2026 for all categories and countries, plus a look ahead at what the future holds for the Upper GIs market globally.
The report also includes: an in-depth look at the latest scientific studies and case studies of key brands, highlighting success factors, sales, NPD and advertising activity.
Order this report
This report is an in-depth exploration of the Upper Gastrointestinals market, including antacids, antiflatulents, antinauseants, digestive enzymes and liver & bile remedies and includes coverage of 15 major markets from across the globe, with topline sales, brand performances, new developments, launches and A+P campaigns.
Why buy this report?
"PPI switches gave the Upper GIs market a new lease of life in recent years, while traditional antacids saw a resurgence thanks to their strong consumer heritage. Our in-depth report examines the market for antacids – plus antiflatulents, antinauseants, digestive enzymes and liver & bile remedies – in 15 major countries around the globe."
Nicholas Hall